Caprock Group, Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Caprock Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$12.09 - $15.0 $3,240 - $4,020	-268 Reduced 2.53%	10,338 $128,000
Q1 2023 Apr 26, 2023	SELL	$12.99 - $16.48 $7,079 - $8,981	-545 Reduced 4.89%	10,606 $148,000
Q4 2022 Jan 23, 2023	SELL	$12.5 - $24.78 $3,600 - $7,136	-288 Reduced 2.52%	11,151 $0
Q3 2022 Nov 07, 2022	BUY	$20.6 - $30.37 $30,652 - $45,190	1,488 Added 14.95%	11,439 $292,000
Q2 2022 Jul 26, 2022	BUY	$26.05 - $37.48 $5,678 - $8,170	218 Added 2.24%	9,951 $283,000
Q1 2022 Apr 12, 2022	BUY	$24.46 - $40.92 $17,757 - $29,707	726 Added 8.06%	9,733 $343,000
Q4 2021 Jan 18, 2022	BUY	$35.0 - $45.94 $315,245 - $413,781	9,007 New	9,007 $377,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.